A controlled access aerosolized particle enclosure for isolation of airborne contaminants includes a frame defining a patient isolation region over a patient bed. A linkage attaches the framed enclosure to a patient treatment vehicle, and a flexible elasticized barrier is suspended by the frame for enclosing the patient isolation region. The barrier is formed from deformable planer sheets of a flexible transparent material and extending adjacent to the patient treatment surface forming a draped edge around the bed or transport. A low pressure source is in fluidic engagement with the enclosure for reducing a pressure within the enclosure below that of ambient surroundings, such that the low pressure source provides a pressure for drawing the elasticized barrier against the patient treatment surface for restricting airborne particle passage from the enclosure to the ambient surroundings, but limits the negative pressure to avoid substantial deformation or collapse of the enclosure.
A61G 10/02 - Treatment rooms for medical purposes with artificial climateTreatment rooms for medical purposes with means to maintain a desired pressure, e.g. for germ-free rooms
A portable home healthcare workstation defines a wheeled enclosure and telescoping, angled worksurface transportable to a patient home or domicile bedside. A telescoping handle extends for supporting the worksurface at a suitable height, and an angular pivot allows the worksurface to be oriented for ease of access to patient records or temporary storage of medical supplies. An accessory container attaches to the telescoped uprights and provides containment of equipment and supplies, and detaches for storage in the enclosure. A stabilizer extends horizontally from the uprights, and together with the attached enclosure and base provide support on opposed sides of the uprights for maintaining a substantially vertical orientation to support the worksurface. Retraction of the stabilizer allows the worksurface to be received in the enclosure for wheeled portability, and collapsing of the telescoped uprights allows for handcarry capability.
A gastrocutaneous closure device allows gastrocutaneous fistula closure from external abdominal access through the fistula site. Access through the fistula ensures accurate closure placement on the interior lumen wall of the stomach. A closure or clip has a plurality of prongs defined by a deformable material, such that the prongs extend radially from a central hub in an arcuate or curved, semicircular shape. The arcuate shape converges towards a central point or axis at a distal end, and the proximate end of the prongs attaches to the central hub such that the prongs radiate from the hub and the distal end curves back toward the axis through the hub. The deformable prongs may therefore radially compress or retract to define a larger or smaller diameter. The fistula lies on the axis such that the biased, inserted prongs pull the inner stomach wall closed around the healing fistula.
A61B 17/00 - Surgical instruments, devices or methods
A61B 18/00 - Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
A61B 18/06 - Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating caused by chemical reaction
A device to screen for and treat cervical precancerous lesions combines features in an examination and treatment device, including an examination portal defined by an elongated body adapted for visual observation of an examination area, and an imaging apparatus disposed in an interior of the examination portal for capturing images of the examination area. An automated analysis with higher diagnostic accuracy may also be performed. A treatment probe is adapted for access to the examination area, such that the treatment probe is responsive to operator control for remedial medical contact with the examination area. Premalignant and some malignant lesions can often be treated by surface remedies such as electrocautery, cryotherapy, laser therapy, chemical ablation, or excision. The treatment probe is operable from the operator position concurrently with rendering of the captured images, combining the diagnosis and treatment procedures in the same examination, visit or transaction.
A61B 1/00 - Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopesIlluminating arrangements therefor
A61B 1/05 - Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopesIlluminating arrangements therefor combined with photographic or television appliances characterised by the image sensor, e.g. camera, being in the distal end portion
A61B 18/02 - Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
G16H 50/70 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
A controlled access aerosolized particle enclosure for isolation of airborne contaminants includes a frame defining a patient isolation region over a patient bed. A linkage attaches the framed enclosure to a patient treatment vehicle, and a flexible elasticized barrier is suspended by the frame for enclosing the patient isolation region. The barrier is formed from deformable planer sheets of a flexible transparent material and extending adjacent to the patient treatment surface forming a draped edge around the bed or transport. A low pressure source is in fluidic engagement with the enclosure for reducing a pressure within the enclosure below that of ambient surroundings, such that the low pressure source provides a pressure for drawing the elasticized barrier against the patient treatment surface for restricting airborne particle passage from the enclosure to the ambient surroundings, but limits the negative pressure to avoid substantial deformation or collapse of the enclosure.
A61G 10/02 - Treatment rooms for medical purposes with artificial climateTreatment rooms for medical purposes with means to maintain a desired pressure, e.g. for germ-free rooms
A controlled access aerosolized particle enclosure for isolation of airborne contaminants includes a frame defining a patient isolation region over a patient bed. A linkage attaches the framed enclosure to a patient treatment vehicle, and a flexible elasticized barrier is suspended by the frame for enclosing the patient isolation region. The barrier is formed from deformable planer sheets of a flexible transparent material and extending adjacent to the patient treatment surface forming a draped edge around the bed or transport. A low pressure source is in fluidic engagement with the enclosure for reducing a pressure within the enclosure below that of ambient surroundings, such that the low pressure source provides a pressure for drawing the elasticized barrier against the patient treatment surface for restricting airborne particle passage from the enclosure to the ambient surroundings, but limits the negative pressure to avoid substantial deformation or collapse of the enclosure.
A61G 10/02 - Treatment rooms for medical purposes with artificial climateTreatment rooms for medical purposes with means to maintain a desired pressure, e.g. for germ-free rooms
16 - Paper, cardboard and goods made from these materials
Goods & Services
Medical teaching and instructional aids in the nature of simulated renderings and props of pathogens, compromised tissue, and growths caused by medical ailments for patient education purposes, namely, three dimensional anatomical models of lung nodules for patient education purposes
Board of Trustees of the University of Maine System (USA)
Inventor
Ecker, Robert D.
Shahinpoor, Mohsen
Abstract
The present disclosure relates to electrically controllable surgical tools. In general, surgical devices are provided having an electrically controllable, fingered operating end for use in angiography, endovascular and/or neurological surgery. The finger(s) at the operating end can be made from ionic polymer metal composite (IPMC) material to facilitate control of the finger(s).
A61B 17/22 - Implements for squeezing-off ulcers or the like on inner organs of the bodyImplements for scraping-out cavities of body organs, e.g. bonesSurgical instruments, devices or methods for invasive removal or destruction of calculus using mechanical vibrationsSurgical instruments, devices or methods for removing obstructions in blood vessels, not otherwise provided for
A61B 17/50 - Instruments for removing foreign bodies from the human body
A61B 17/00 - Surgical instruments, devices or methods
A61B 17/12 - Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
A gastrocutaneous closure device allows gastrocutaneous fistula closure from external abdominal access through the fistula site. Access through the fistula ensures accurate closure placement on the interior lumen wall of the stomach. A closure or clip has a plurality of prongs defined by a deformable material, such that the prongs extend radially from a central hub in an arcuate or curved, semicircular shape. The arcuate shape converges towards a central point or axis at a distal end, and the proximate end of the prongs attaches to the central hub such that the prongs radiate from the hub and the distal end curves back toward the axis through the hub. The deformable prongs may therefore radially compress or retract to define a larger or smaller diameter. The fistula lies on the axis such that the biased, inserted prongs pull the inner stomach wall closed around the healing fistula.
A gastrocutaneous closure device allows gastrocutaneous fistula closure from external abdominal access through the fistula site. Access through the fistula ensures accurate closure placement on the interior lumen wall of the stomach. A closure or clip has a plurality of prongs defined by a deformable material, such that the prongs extend radially from a central hub in an arcuate or curved, semicircular shape. The arcuate shape converges towards a central point or axis at a distal end, and the proximate end of the prongs attaches to the central hub such that the prongs radiate from the hub and the distal end curves back toward the axis through the hub. The deformable prongs may therefore radially compress or retract to define a larger or smaller diameter. The fistula lies on the axis such that the biased, inserted prongs pull the inner stomach wall closed around the healing fistula.
A61B 17/00 - Surgical instruments, devices or methods
A61B 18/06 - Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating caused by chemical reaction
Various exemplary angled surgical trocars and methods of using angled surgical trocars are provided. In general, a trocar configured to be advanced into a body of a patient can have an angled distal portion. The trocar can have a cut-out at its distal end in the angled distal portion of the trocar. The trocar can be advanced into the patient's body alone or with an obturator located therein. The obturator located in the trocar can have a flexible portion configured to bend within the trocar's angled distal portion. The trocar and obturator can be used in a variety of medical procedures, for example thoracic procedures in which the trocar is used to provide access to a thoracic cavity of a patient.
The present disclosure relates to electrically controllable surgical tools. In general, surgical devices are provided having an electrically controllable, fingered operating end for use in angiography, endovascular and/or neurological surgery. The finger(s) at the operating end can be made from ionic polymer metal composite (IPMC) material to facilitate control of the finger(s).
A61B 17/22 - Implements for squeezing-off ulcers or the like on inner organs of the bodyImplements for scraping-out cavities of body organs, e.g. bonesSurgical instruments, devices or methods for invasive removal or destruction of calculus using mechanical vibrationsSurgical instruments, devices or methods for removing obstructions in blood vessels, not otherwise provided for
A61B 17/50 - Instruments for removing foreign bodies from the human body
A61B 17/00 - Surgical instruments, devices or methods
A61B 17/12 - Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
13.
Compositions and methods for treating inflammation and fibrosis
The present invention features compositions featuring agents that bind to denatured collagen and methods of using such agents to treat or prevent fibrosis or inflammation in a subject.
The present invention features compositions and methods for treating and preventing a metabolic syndrome featuring the collagen triple helix repeat containing-1 (Cthrc1) protein.
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
A01K 67/027 - New or modified breeds of vertebrates
C07K 16/18 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans
G01N 33/68 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving proteins, peptides or amino acids
C07K 14/78 - Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
C07K 14/435 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
C07K 14/47 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans from vertebrates from mammals
A61K 48/00 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseasesGene therapy
The invention provides methods for the treatment of coronary heart disease, peripheral vascular disease, stroke, and ischemia featuring agents that interfere with the expression or activity of Cthrc1. The invention also provides the use of Cthrc1 peptide as a therapeutic agent for the treatment of acute or chronic cardiac deficiencies. The invention further provides detection and monitoring of Cthrc1 peptide in blood or serum to assess or monitor cardiac function.
C07K 16/18 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
C07K 14/47 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans from vertebrates from mammals
C07K 14/78 - Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
The present invention provides a method of treating cancer using the sodium salt of a benzoic acid derivative, alone or in combination with standard treatments such as chemotherapy and radiotherapy.
